Qualifications
Skills
Professional presentation skills
Strong interpersonal communication, both verbal and written
Teamwork, commitment, and self-responsibility
Independent and flexible working style, combined with good business acumen
Credibility and contacts within the diabetes community
Basic computer skills
Fluent in German, both spoken and written
English is desirable
Education and Experience
Proven experience in training and/or treating pump patients or equivalent education and experience
Diabetes Advisor DDG is preferred
Previous industry experience is desirable
Certified nutritionist is an advantage
Excellent communication skills, both written and verbal
Experience in dealing directly with healthcare professionals and diabetes patients
Physical Requirements
Valid driving license required.
Regular business travel is necessary, primarily by car within the assigned region.
Overnight trips may vary, typically ranging from 2 to 5 nights per month.
Work environment includes clinics and practices in the area, as well as a home office.
A company car will be provided.
What we offer:
A young and growing company with a collaborative environment.
A responsible role with creative freedom.
Flexible working hours and the option to work from home.
Company pension, disability insurance, and the opportunity to participate in the Insulet share program.
Notes for employment agencies/recruiters
Insulet does not accept advertising from employment agencies/recruiters. Candidates submitted or presented by recruitment agencies without a fully completed talent acquisition approval or through this website will not be considered part of an assignment for which the agency can demand compensation. Hiring managers and/or other Insulet employees are not authorized to engage the services of agencies directly and any resumes sent directly to Insulet hiring managers and/or employees (without a currently active Insulet talent acquisition approval on file) will be considered unpaid referrals and Insulet will owe no fee to the agency if these individuals are hired.
NOTE: This position requires on-site work (travel required in assigned territory). #LI-Remote
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.
We are looking for highly motivated, performance-driven individuals to be a part of our expanding team. We do this by hiring amazing people guided by shared values who exceed customer expectations. Our continued success depends on it!
Please read our Privacy Notice to learn how Insulet handles your personal information when you apply for a vacancy with us here.
","datePosted":"2025-03-13T02:28","employmentType":"FULL_TIME","jobLocation":[{"@type":"Place","address":{"@type":"PostalAddress","addressLocality":"Lichtenfels, Germany","addressRegion":null,"addressCountry":"Germany"}},{"@type":"Place","address":{"@type":"PostalAddress","addressLocality":"Jena, Germany","addressRegion":null,"addressCountry":"Germany"}},{"@type":"Place","address":{"@type":"PostalAddress","addressLocality":"Cottbus, Germany","addressRegion":null,"addressCountry":"Germany"}},{"@type":"Place","address":{"@type":"PostalAddress","addressLocality":"Germany","addressRegion":null,"addressCountry":"Germany"}},{"@type":"Place","address":{"@type":"PostalAddress","addressLocality":"Dresden, Germany","addressRegion":null,"addressCountry":"Germany"}}],"directApply":false,"hiringOrganization":{"@type":"Organization","name":"Insulet Corporation","sameAs":"https://www.insulet.com/","logo":"https://storage.googleapis.com/simplify-imgs/companies/dc2cf0d7-af5f-4a5c-9c42-8fa0bd0ae04d/logo.png"},"identifier":{"@type":"PropertyValue","name":"Insulet Corporation","value":"dc2cf0d7-af5f-4a5c-9c42-8fa0bd0ae04d"}}Full-Time
Develops tubeless insulin delivery systems
No salary listed
Senior
Lichtenfels, Germany + 4 more
More locations: Jena, Germany | Cottbus, Germany | Germany | Dresden, Germany
This position requires on-site work (travel required in assigned territory).
Get referrals →
You have ways to get a Insulet Corporation referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 5 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Insulet Corporation develops medical devices aimed at simplifying life for people with diabetes. Their main product, the Omnipod Insulin Management System, is a tubeless device that delivers insulin continuously for up to three days without needles. The Omnipod 5 Automated Insulin Delivery System integrates with a continuous glucose monitor, allowing users to manage blood sugar without multiple injections or fingersticks. Insulet differentiates itself by providing a user-friendly solution that enhances insulin management, with the goal of improving the quality of life for individuals with diabetes.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Acton, Massachusetts
Founded
2000
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Insulet Corp. (PODD), a medical device company, on Monday announced that Chief Executive Officer Jim Hollingshead has resigned from the Board of Directors.
Ashley McEvoy has been tapped to be president and CEO of Insulet.
Insulet competes with companies like DexCom, Tandem Diabetes Care, and Masimo Corporation in the diabetes care market.
Insulet raises $444.4M through senior notes to refinance existing convertible debt. Strategic move positions medical device maker for future growth while optimizing capital structure.
Insulet (NASDAQ: PODD) will present results from its multinational RADIANT trial at the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in March 2025.